Atherosclerosis/Cardiovascular Disease

= ILF Board Member Author(s)

Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST)

Female-friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial:

baseline characteristics

Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium

density in Japanese men

The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the

general population.

Icosapent ethyl: Where will it fit into guideline-based medical therapy for high risk atherosclerotic cardiovascular disease?

Clinical, Electrocardiographic, and Echocardiographic Features in Hospitalized Nonagenarians (90+): Comparison between the Genders

High-sensitivity Cardiac Troponin and Natriuretic Peptide in Persons Without Cardiovascular Disease and Subsequent Risk of Infection: Atherosclerosis Risk in Communities Study


The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.

Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via

modulation of the innate immune system

Dietary fat composition: replacement of saturated fatty acids with PUFA as a public health strategy, with an emphasis on α-linolenic acid

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes

Trends and Costs Associated With Suboptimal Physical Activity Among US Women With

Cardiovascular Disease

Ranolazine Reduces Angina in Women with Ischemic Heart Disease: Results of an Open-Label,

Multicenter Trial

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term

changes in multiple risk markers

Cancer Survivorship and Subclinical Myocardial Damage: The Atherosclerosis Risk in Communities (ARIC) Study.

Endovascular Thrombectomy as a Means to Improve Survival in Acute Ischemic Stroke: A Meta-analysis.

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Percutaneous Transcatheter Mitral Valve Replacement - First-in-Human Experience With a New Transseptal System

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.

Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults

Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction

Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.

Health Factors Associated with Cardiovascular Wellness

Cardiovascular risk algorithms in primary care: Results from the DETECT study

Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography

Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease.

Cardiovascular Benefits of GLP-1 Receptor Agonism - Is Inflammation a Key?

Composite Cardiovascular Risk Factor Target Achievement and its Predictors in US Adults with Diabetes:

The Diabetes Collaborative Registry

Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency.

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease


Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

REDUCE IT Commentary from Dr. Howard Weintraub

Slides from Paul D. Rosenblit, MD, PhD, FACE, FNLA

View Full Article

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

REDUCE IT Summary from Eliot Brinton

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events


Endothelial cell CD36 optimizes tissue fatty acid uptake

triglycerides oct18.jpg

Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.

Percutaneous Coronary Intervention.png

Association of Same-Day Discharge After Elective Percutaneous Coronary Intervention in the United States With Costs and Outcomes


Cardiovascular risk profile in Olympic athletes: an unexpected and underestimated risk scenario.


Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) 

Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome

Post-stroke losartan and captopril treatments arrest hemorrhagic expansion in SHRsp without lowering blood pressure.

Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease

C/EBPβ Acts Upstream of NF-κB P65 Subunit in Ox-LDL-Induced IL-1β Production by Macrophages.

Differential Effects of Estradiol and Progesterone on Cardiovascular Risk Factors in Postmenopausal Women

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Nonvalvular Atrial fibrillation Patients with a Non-Sex-Related CHA2DS2-VASc Score of 1.

Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol

Lipotoxicty in yeast: a focus on plasma membrane signalling and membrane contact sites.

Residual Inflammatory Risk On Treatment with PCSK9 Inhibition and Statin Therapy.

Utility of glycated hemoglobin screening in patients undergoing elective coronary artery surgery: Prospective, cohort study from the E-CABG registry.

Pericardial and visceral, but not total body fat, are related to global coronary and extra-coronary atherosclerotic plaque burden.

HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.

Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors and distal sensorimotor polyneuropathy: KORA F4/FF4 study.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCIRandomized Clinical Trial.

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.

Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT.

Slides from Matthew Budoff, MD

Summary from Matthew Budoff, MD

Insulin-Leptin Axis, Cardiometabolic Risk and Oxidative Stress in Elderly with Metabolic Syndrome.

Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.

Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients.

Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.

Carotid artery ultrasound texture, cardiovascular risk factors, and subclinical arterial disease: the multi-ethnic study of atherosclerosis (MESA).

Canakinumab for secondary prevention of atherosclerotic disease.

CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.

Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.

Revised Framingham Stroke Risk Score, Nontraditional Risk Markers, and Incident Stroke in a Multiethnic Cohort.

Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices

Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.

Coronary Plaque Microstructure and Composition Modify Optical Polarization: A New Endogenous Contrast Mechanism for Optical Frequency Domain Imaging.

Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.

Elevated blood pressure during emergency departments visit is associated with increased rate of hospitalization for heart failure: A retrospective cohort study.

Diagnosis and Treatment of Hypertension in the 2017 ACC/AHA Guidelines and in the Real World

A bundled quality improvement program to standardize clinical blood pressure measurement in primary care.

Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.

Blood Pressure Trajectories in the 20 Years Before Death